Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment.
Saved in:
| Title: | Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. |
|---|---|
| Authors: | Andreatos N; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., McGarrah PW; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., Sonbol MB; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA., Starr JS; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Capdevila J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. halfdanarson.thorvardur@mayo.edu. |
| Source: | Current oncology reports [Curr Oncol Rep] 2023 Oct; Vol. 25 (10), pp. 1127-1139. Date of Electronic Publication: 2023 Aug 22. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
